Thu Jan 30 06:40:43 UTC 2025: **Pune GBS Outbreak Alarms India: 111 Cases, One Death Reported**
**Bengaluru, January 30, 2025** – A significant outbreak of Guillain-Barré syndrome (GBS), a rare neurological disorder, in Pune, Maharashtra, has raised serious concerns across India. As of January 28th, 111 cases and one death have been reported since the first case emerged on January 9th. This unprecedented surge in GBS cases is alarming, exceeding all but two previous global outbreaks in recent history (French Polynesia, 2013-14; Peru, 2019).
GBS causes muscle weakness, tingling, numbness, and pain. Severe cases can affect breathing and heart function, making it a medical emergency. While the annual global incidence is low (1-2 per 100,000), the Pune outbreak highlights a potential public health crisis.
According to leading experts Dr. Monojit Debnath and Dr. Madhu Nagappa from NIMHANS, Bengaluru, GBS is often triggered by infections, particularly Campylobacter jejuni, though other viruses and bacteria are implicated. Their research indicates a complex interplay of multiple pathogens and immune system responses. While infection is a common precursor, not all infections lead to GBS, and not all GBS cases have a clear infectious cause.
Treatment involves plasma exchange or intravenous immunoglobulin, both equally effective. While most patients recover fully, some experience long-term disability. The doctors emphasize that GBS is not contagious but advise practicing good hygiene to minimize the risk of infection. They also highlight the need for more global epidemiological data on GBS, especially in low- and middle-income countries where infections and exposure are often higher.
First Piper 